Short description
MedTech startup developing an automated IVD medical device for detecting and identifying all human pathogens & AMR genes on one test panel.
Description
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time.
Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Los Angeles, California, United States, North America
Founded on
July 1, 2020
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Absolutely Noaccess
Sign in for full access
Founders
Chris Pham, Dr. Mike Fang, John Mickel, Joseph Mickel, Paul Spiegel Esq.